The interaction between gut inflammatory processes and stress is gaining increasing recognition. Corticotropin-releasing factor (CRF)-receptor activation in the brain is well established as a key signaling pathway initiating the various components of the stress response including in the viscera. In addition, a local CRF signaling system has been recently established in the gut. This review summarize the present knowledge on mechanisms through which both brain and gut CRF receptors modulate intestinal inflammatory processes and its relevance towards increased inflammatory bowel disease (IBD) activity and post-infectious irritable bowel syndrome (IBS) susceptibility induced by stress.
Introduction
In the past years, the influence of psychosocial and environmental stressors on the pathogenesis of ''stress-associated" illnesses such as obesity, metabolic syndrome, and type 2 diabetes mellitus, as well as, pain and chronic fatigue syndromes, received increased awareness (Miller et al., 2009; Muscatell et al., 2009) . Early on Hans Selye, who coined the term stress, noticed that the gastrointestinal tract and immune systems are particularly responsive to stressors (Selye, 1936) . A growing consensus recognized the association of stressful life experiences, and the development and/or exacerbation of functional bowel disorders, such as irritable bowel syndrome (IBS) (Barreau et al., 2008; De Giorgio and Barbara, 2008; Santos et al., 2008; Stengel and Taché, 2009; Taché and Brunnhuber, 2008) , and inflammatory bowel disease (IBD) activity (Maunder and Levenstein, 2008; Mawdsley and Rampton, 2005; Santos et al., 2008) . IBD, which includes Crohn's disease and ulcerative colitis (UC), is associated with a measurable inflammatory response leading to gut tissue damage (Shih and Targan, 2008) . IBS patients, on the other hand, display no or in some cases only low-grade colonic mucosal inflammation (De Giorgio and Barbara, 2008) . IBS, as defined by Rome III criteria, is characterized by recurrent abdominal pain or discomfort associated with constipation and/or diarrhea, and may show some overlap with microscopic colitis (De Giorgio and Barbara, 2008; Limsui et al., 2007) . IBS causes long-lasting discomfort and distress in patients, however neither leads to intestinal damage, nor increases the incidence of cancer or chronic inflammatory state. In addition, IBS is a highly prevalent functional bowel disorder, which accounts for up to 40% of gastroenterology outpatients, hence making it an important clinical entity (Taché and Brunnhuber, 2008) .
The association or impact of psychosocial factors on IBD and IBS prompted investigations to unravel the contributions of stress-related mechanisms in their pathophysiology in order to develop novel therapeutic options targeting these pathways. One principal effector of stress responsive systems is the 41-amino acid corticotropin-releasing factor (CRF) that is released in the brain in response to stressors and plays a pivotal role to activate the hypothalamic-pituitary-adrenal (HPA) axis (Lightman, 2008) . Brain CRF also acts as a neurotransmitter to modulate behavior and activity of the autonomic nervous system (Taché et al., 2009 ). In addition, the gut contains peripheral CRF signaling pathways (Fekete and Zorrilla, 2007; Stengel and Taché, 2009; Taché and Bonaz, 2007) 
